ALL-BFM 95 Treatment in Turkish Children with Acute Lymphoblastic Leukemia—Experience of a Single Center

REFERENCES

• Schrappe M. Evolution of BFM trials for childhood ALL. Ann Hematol. 2004;83(Suppl 1):S121–S123.
   PubMedGoogle Scholar
• Ribeiro R, Pui CH. Treatment of acute lymphoblastic leukemia in low- and middle-income countries: challenges and opportunities. Leuk Lymphoma. 2008;49:373–376.
   PubMed Web of Science ®Google Scholar
• Pui CH. Toward a total cure for acute lymphoblastic leukemia. J Clin Oncol. 2009;27:5121–5123.
   PubMed Web of Science ®Google Scholar
• Möricke A, Reiter A, Zimmermann M, , for the German-Austrian-Swiss ALL-BFM Study Group. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2008;111:4477–4489.
   PubMed Web of Science ®Google Scholar
• Möricke A, Zimmermann M, Reiter A, Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia. 2010;24:265 –284.
   PubMed Web of Science ®Google Scholar
• Gu LJ, Li J, Xue HL, Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China. Leuk Lymphoma. 2008;49:488–494.
   PubMed Web of Science ®Google Scholar
• Karachunskiy A, Herold R, von Stackelberg A, Leukemia. Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia. Leukemia. 2008;22:1144–1153.
   PubMed Web of Science ®Google Scholar
• Yetgin S, Cetin M. The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia. Leuk Lymphoma. 2003;44:489–495.
   PubMed Web of Science ®Google Scholar
• Irken G, Oren H, Gulen H, Treatment outcome of adolescents with acute lymphoblastic leukemia. Ann Hematol. 2002;81:641–645.
   PubMed Web of Science ®Google Scholar
• Hazar V, Karasu GT, Uygun V, Childhood acute lymphoblastic leukemia in Turkey: factors influencing treatment and outcome: a single center experience. J Pediatr Hematol Oncol. 2010;32:e317–e322.
   PubMed Web of Science ®Google Scholar
• Kaya Z, Gursel T, Bakkaloglu SA, Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2007;24:257–267.
   PubMed Web of Science ®Google Scholar
• Kaya Z, Gursel T, Kocak U, Invasive fungal infections in pediatric leukemia patients receiving fluconazole prophylaxis. Pediatr Blood Cancer. 2009;52:470–475.
   PubMed Web of Science ®Google Scholar
• Hussein H, Sidhom I, Naga SA, Outcome and prognostic factors of acute lymphoblastic leukemia in children at the National Cancer Institute, Egypt. J Pediatr Hematol Oncol. 2004;26:507–514.
   PubMed Web of Science ®Google Scholar
• Bajel A, George B, Mathews V, Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol. Pediatr Blood Cancer. 2008;51:621–625.
   PubMed Web of Science ®Google Scholar
• Attarbaschi A, Mann G, Dworzak M, et al; Austrian Cooperative Study Group. Treatment results of childhood acute lymphoblastic leukemia in Austria—a report of 20 years’ experience. Wien Klin Wochenschr. 2002;114:148–157.
   PubMed Web of Science ®Google Scholar
• Aricò M, Valsecchi MG, Rizzari C, Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Munster based chemotherapy. J Clin Oncol. 2008;26:283–289.
   PubMed Web of Science ®Google Scholar
• Pui CH, Pei D, Sandlund JT, Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia. 2010;24:371–382.
   PubMed Web of Science ®Google Scholar
• Nachman JB, La MK, Hunger SP, Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group. J Clin Oncol. 2009;27:5189–5194.
   PubMed Web of Science ®Google Scholar
• Moghrabi A, Levy DE, Asselin B, Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95–01 for children with acute lymphoblastic leukemia. Blood. 2007;109:896–904.
   PubMed Web of Science ®Google Scholar
• Mitchell C, Richards S, Harrison CJ, Eden T. Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980–2001. Leukemia. 2010;24:406–418.
   PubMed Web of Science ®Google Scholar
• Laks D, Longhi F, Wagner MB, Garcia PC. Survival evaluation of children with acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munich trial. J Pediatr (Rio J). 2003;79:149–158.
   PubMedGoogle Scholar
• Sackmann-Muriel F, Felice MS, Zubizarreta PA, Treatment results in childhood acute lymphoblastic leukemia with a modified ALL-BFM’90 protocol: lack of improvement in high-risk group. Leuk Res. 1999;23:331–340.
   PubMed Web of Science ®Google Scholar
• Buendia MT, Lozano JM, Suarez GE, The impact of acute lymphoblastic leukemia treatment on central nervous system results in Bogota, Colombia. J Pediatr Hematol Oncol. 2008;30:643–650.
   PubMed Web of Science ®Google Scholar
• Gao YJ, Lu FJ, Wang HS. Treating childhood acute lymphoblastic leukemia in a developing country 1998–2003: the experience of a single children's hospital in China. Pediatr Hematol Oncol. 2006;28:798–802.
   Web of Science ®Google Scholar
• Bonilla M, Moreno N, Marina N, Acute lymphoblastic leukemia in a developing country: preliminary results of a nonrandomized clinical trial in El Salvador. J Pediatr Hematol Oncol. 2000;22:495–501.
   PubMed Web of Science ®Google Scholar
• Magrath I, Shanta V, Advani S, Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period. Eur J Cancer. 2005;41:1570–1583.
   PubMed Web of Science ®Google Scholar